SILVERARC CAPITAL MANAGEMENT, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001816307

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2023 · 72 positions · Total reported value $263.23M · Top-10 concentration 40.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 64.6% · 15 new · 20 cut · 18 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.8% · vs SPY -10.9% · Prev Value $855.33M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.7% · vs SPY -6.9% · Latest Value $784.53M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, SILVERARC CAPITAL MANAGEMENT, LLC disclosed 72 equity positions with a combined reported value of $263.23M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 40.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were XBI ($21.91M), MORF ($13.54M), MRUS ($11.79M). By sector, the heaviest allocations are Health Care 56.4%, Industrials 0.7%.

Versus the prior quarter, SILVERARC CAPITAL MANAGEMENT, LLC opened 15 new positions, trimmed 20 and fully exited 18, a turnover rate of 64.6% of positions.

The largest new positions opened in Q3 2023 were XBI ($21.91M), MORF ($13.54M), MRUS ($11.79M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • XBI SPDR SERIES TRUST · $21.91M
  • MORF MORPHIC HLDG INC · $13.54M
  • MRUS MERUS N V · $11.79M
  • SLNO SOLENO THERAPEUTICS INC · $10.92M
  • ITCI INTRA CELLULAR THERAPIES INC · $10.87M
  • PSTX POSEIDA THERAPEUTICS INC · $8.49M
  • KRYS KRYSTAL BIOTECH INC · $8.30M
  • BIIB BIOGEN INC · $7.21M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest SILVERARC CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Silverarc Capital Management is an SEC-registered 13F filer based in Boston, MA, United States. As of Q2 2026 it reported 67 US equity positions with a combined value of $855.33M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-116845 (status: Approved), registered 2019-06-21
  • Regulatory AUM (Form ADV): $1.61B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds
  • Website: silverarccapital.com

Portfolio Structure

  • 67 positions · $855.33M reported value (Q2 2026)
  • Top 10 holdings = 47.1% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 6.4%
  • Average position size: $12.77M

Sector Tilt

  • Health Care 98.1%
  • Financials 1.9%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 19 new, 16 added, 28 reduced, 20 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 56.4%
Other 42.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 300.00K $21.91M 8.32%
8.32%
New
2 590.83K $13.54M 5.14%
5.14%
New
3 500.00K $11.79M 4.48%
4.48%
New
4 370.00K $10.92M 4.15%
4.15%
New
5 208.73K $10.87M 4.13%
4.13%
New
6 3.57M $8.49M 3.23%
3.23%
New
7 71.53K $8.30M 3.15%
3.15%
New
8 28.07K $7.21M 2.74%
2.74%
New
9 508.88K $7.13M 2.71%
2.71%
New
10 31.42K $7.10M 2.70%
2.70%
New
11 4.12M $7.04M 2.67%
2.67%
New
12 1.12M $6.80M 2.58%
2.58%
New
13 220.00K $6.54M 2.49%
2.49%
New
14 150.00K $6.53M 2.48%
2.48%
New
15 651.37K $6.35M 2.41%
2.41%
New
16 260.54K $5.97M 2.27%
2.27%
New
17 1.26M $5.89M 2.24%
2.24%
New
18 791.67K $5.61M 2.13%
2.13%
New
19 60.00K $5.46M 2.07%
2.07%
New
20 239.57K $5.35M 2.03%
2.03%
New
21 6.13M $5.11M 1.94%
1.94%
New
22 407.80K $5.04M 1.91%
1.91%
New
23 10.00K $4.87M 1.85%
1.85%
New
24 13.77K $4.79M 1.82%
1.82%
New
25 62.79K $4.71M 1.79%
1.79%
New
26 250.41K $4.34M 1.65%
1.65%
New
27 892.79K $4.27M 1.62%
1.62%
New
28 250.00K $3.97M 1.51%
1.51%
New
29 490.47K $3.92M 1.49%
1.49%
New
30 150.39K $3.80M 1.44%
1.44%
New
31 110.11K $3.48M 1.32%
1.32%
New
32 200.00K $2.98M 1.13%
1.13%
New
33 564.00K $2.75M 1.05%
1.05%
New
34 404.04K $2.67M 1.01%
1.01%
New
35 500.00K $2.52M 0.95%
0.95%
New
36 354.61K $2.24M 0.85%
0.85%
New
37 228.93K $2.20M 0.84%
0.84%
New
38 927.41K $2.02M 0.77%
0.77%
New
39 1.11M $2.01M 0.76%
0.76%
New
40 1.20M $1.95M 0.74%
0.74%
New
41 54.00K $1.84M 0.70%
0.70%
New
42 3.10M $1.82M 0.69%
0.69%
New
43 53.02K $1.68M 0.64%
0.64%
New
44 31.34K $1.58M 0.60%
0.60%
New
45 100.00K $1.36M 0.52%
0.52%
New
46 26.63K $1.28M 0.49%
0.49%
New
47 100.00K $1.17M 0.44%
0.44%
New
48 41.45K $1.16M 0.44%
0.44%
New
49 9.20K $1.11M 0.42%
0.42%
New
50 801.60K $1.02M 0.39%
0.39%
New

FAQ

What did SILVERARC CAPITAL MANAGEMENT, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, SILVERARC CAPITAL MANAGEMENT, LLC reported 72 equity positions worth $263.23M in aggregate; its largest disclosed positions were XBI ($21.91M), MORF ($13.54M), MRUS ($11.79M).

How large is SILVERARC CAPITAL MANAGEMENT, LLC's portfolio?

SILVERARC CAPITAL MANAGEMENT, LLC reported $263.23M of long equity holdings across 72 positions as of 2023-Q3. Top-10 holdings account for 40.7% of reported value.

What is SILVERARC CAPITAL MANAGEMENT, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/silverarc-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →